Back to Search Start Over

The changing face of antibiotic therapy.

Source :
British journal of hospital medicine (London, England : 2005) [Br J Hosp Med (Lond)] 2009 Oct; Vol. 70 (10), pp. 586-7.
Publication Year :
2009

Abstract

Antimicrobial resistance is one of the biggest challenges facing the NHS. Part of the solution is education and improved prescribing by doctors. Janssen-Cilag sponsored a meeting in May 2009 in Glasgow focussing on doripenem, a new carbapenem. This report highlights the role of doripenem in health-care-associated infection control.

Subjects

Subjects :
Anti-Bacterial Agents economics
Carbapenems economics
Cross Infection economics
Delayed-Action Preparations
Doripenem
Humans
Infection Control economics
Treatment Outcome
Anti-Bacterial Agents therapeutic use
Carbapenems therapeutic use
Cross Infection drug therapy
Drug Resistance, Bacterial
Infection Control methods

Details

Language :
English
ISSN :
1750-8460
Volume :
70
Issue :
10
Database :
MEDLINE
Journal :
British journal of hospital medicine (London, England : 2005)
Publication Type :
Academic Journal
Accession number :
19966705
Full Text :
https://doi.org/10.12968/hmed.2009.70.10.44627
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details